[1]
2019. Outcome analysis of acute myeloid leukemia patients treated with high dose daunorubicin. Biomedical Research and Therapy. 6, 9 (Sep. 2019), 3347–3351. DOI:https://doi.org/10.15419/bmrat.v6i9.562.